Utrecht, Netherlands-based developer of an autonomous blood drawing device
Vitestro has raised €92M across 3 funding rounds from 15 investors, most recently a Series B round in Mar 2026. Based in Utrecht, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-03-10 | Series B | €60M | EIC Fund,Fred Moll,InterVest,Invest-NL,Labcorp Venture Fund,Mayo Clinic+7 more | View deal → |
| 2024-04-30 | Other | €20M | Invest-NL,NYBC Ventures,Private Investors,Sonder Capital,The European Innovation Council Fund (EIC Fund) | View deal → |
| 2023-03-21 | Series A | €12M | Sonder Capital | View deal → |
